Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 666 | 2018 |
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021 | 425 | 2021 |
Review of the diagnosis and treatment of periodic paralysis JM Statland, B Fontaine, MG Hanna, NE Johnson, JT Kissel, VA Sansone, ... Muscle & nerve 57 (4), 522-530, 2018 | 259 | 2018 |
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 215 | 2019 |
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial JM Statland, BN Bundy, Y Wang, DR Rayan, JR Trivedi, VA Sansone, ... Jama 308 (13), 1357-1365, 2012 | 204 | 2012 |
Consensus-based care recommendations for adults with myotonic dystrophy type 1 T Ashizawa, C Gagnon, WJ Groh, L Gutmann, NE Johnson, G Meola, ... Neurology: Clinical Practice 8 (6), 507-520, 2018 | 193 | 2018 |
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS M Benatar, L Zhang, L Wang, V Granit, J Statland, R Barohn, A Swenson, ... Neurology 95 (1), e59-e69, 2020 | 190 | 2020 |
Primary lateral sclerosis: consensus diagnostic criteria MR Turner, RJ Barohn, P Corcia, JK Fink, MB Harms, MC Kiernan, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (4), 373-377, 2020 | 189 | 2020 |
Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons JJ Lawrence, F Saraga, JF Churchill, JM Statland, KE Travis, FK Skinner, ... Journal of Neuroscience 26 (47), 12325-12338, 2006 | 188 | 2006 |
Primary lateral sclerosis MA Singer, JM Statland, GI Wolfe, RJ Barohn Muscle & Nerve: Official Journal of the American Association of …, 2007 | 183 | 2007 |
Patterns of weakness, classification of motor neuron disease & clinical diagnosis of sporadic ALS JM Statland, RJ Barohn, AL McVey, J Katz, MM Dimachkie Neurologic clinics 33 (4), 735, 2015 | 148 | 2015 |
Targeting protein homeostasis in sporadic inclusion body myositis M Ahmed, PM Machado, A Miller, C Spicer, L Herbelin, J He, J Noel, ... Science translational medicine 8 (331), 331ra41-331ra41, 2016 | 137 | 2016 |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial J Diaz-Manera, PS Kishnani, H Kushlaf, S Ladha, T Mozaffar, V Straub, ... The Lancet Neurology 20 (12), 1012-1026, 2021 | 135 | 2021 |
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis M Pasnoor, J He, L Herbelin, TM Burns, S Nations, V Bril, AK Wang, ... Neurology 87 (1), 57-64, 2016 | 134 | 2016 |
Cell type‐specific dependence of muscarinic signalling in mouse hippocampal stratum oriens interneurones JJ Lawrence, JM Statland, ZM Grinspan, CJ McBain The Journal of physiology 570 (3), 595-610, 2006 | 132 | 2006 |
Facioscapulohumeral muscular dystrophy JM Statland, R Tawil CONTINUUM: Lifelong Learning in Neurology 22 (6), 1916-1931, 2016 | 124 | 2016 |
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes JR Trivedi, B Bundy, J Statland, M Salajegheh, DR Rayan, SL Venance, ... Brain 136 (7), 2189-2200, 2013 | 114 | 2013 |
Facioscapulohumeral muscular dystrophy JM Statland, R Tawil Neurologic Clinics 32 (3), 721, 2014 | 109 | 2014 |
Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials BC Stunnenberg, J Raaphorst, HM Groenewoud, JM Statland, RC Griggs, ... Jama 320 (22), 2344-2353, 2018 | 108 | 2018 |
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression MD Weiss, EA Macklin, Z Simmons, AS Knox, DJ Greenblatt, N Atassi, ... Neurology 86 (16), 1474-1481, 2016 | 103 | 2016 |